Ausgabe 2/2019
Inhalt (26 Artikel)
One year versus a shorter duration of adjuvant trastuzumab for HER2-positive early breast cancer: a systematic review and meta-analysis
Alessandro Inno, Sandro Barni, Antonio Ghidini, Alberto Zaniboni, Fausto Petrelli
A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients
Hye Won Hwang, Hera Jung, Jiyeon Hyeon, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Jong-Han Yu, Se Kyung Lee, Misun Choi, Soo Youn Cho, Eun Yoon Cho
Surgical trends in breast cancer: a rise in novel operative treatment options over a 12 year analysis
Michael M. Jonczyk, Jolie Jean, Roger Graham, Abhishek Chatterjee
Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy
Fouzia Guestini, Katsuhiko Ono, Minoru Miyashita, Takanori Ishida, Noriaki Ohuchi, Saki Nakagawa, Hisashi Hirakawa, Kentaro Tamaki, Yasuyo Ohi, Yoshiaki Rai, Yasuaki Sagara, Hironobu Sasano, Keely May McNamara
Mucin 2 (MUC2) modulates the aggressiveness of breast cancer
Anna Astashchanka, Thomas M. Shroka, Britta M. Jacobsen
Breast conservation versus mastectomy in patients with T3 breast cancers (> 5 cm): an analysis of 37,268 patients from the National Cancer Database
Anna M. Mazor, Alina M. Mateo, Lyudmila Demora, Elin R. Sigurdson, Elizabeth Handorf, John M. Daly, Allison A. Aggon, Penny R. Anderson, Stephanie E. Weiss, Richard J. Bleicher
High patient satisfaction with a simplified BRCA1/2 testing procedure: long-term results of a prospective study
Martin P. Nilsson, Erik D. Nilsson, Åke Borg, Yvonne Brandberg, Barbro Silfverberg, Niklas Loman
Efficacy of neoadjuvant pertuzumab in addition to chemotherapy and trastuzumab in routine clinical treatment of patients with primary breast cancer: a multicentric analysis
Peter A. Fasching, Andreas D. Hartkopf, Paul Gass, Lothar Häberle, Leyla Akpolat-Basci, Alexander Hein, Bernhard Volz, Florin-Andrei Taran, Naiba Nabieva, Birgit Pott, Friedrich Overkamp, Hanna Einarson, Peyman Hadji, Hans Tesch, Johannes Ettl, Diana Lüftner, Markus Wallwiener, Volkmar Müller, Wolfgang Janni, Tanja N. Fehm, Andreas Schneeweiss, Michael Untch, Dirk Pott, Michael P. Lux, Thomas Geyer, Cornelia Liedtke, Harald Seeger, Sarah Wetzig, Arndt Hartmann, Rüdiger Schulz-Wendtland, Erik Belleville, Diethelm Wallwiener, Matthias W. Beckmann, Sara Y. Brucker, Hans-Christian Kolberg
Prognosis in different subtypes of metaplastic breast cancer: a population-based analysis
Xuexin He, Jiali Ji, Rongrong Dong, Hong Liu, Xiaolan Dai, Chongjian Wang, Francisco J. Esteva, Sai-Ching Jim Yeung
Sentinel lymph node biopsy without axillary lymphadenectomy after neoadjuvant chemotherapy is accurate and safe for selected patients: the GANEA 2 study
Jean-Marc Classe, Cecile Loaec, P. Gimbergues, S. Alran, C. Tunon de Lara, P. F. Dupre, Roman Rouzier, C. Faure, N. Paillocher, M. P. Chauvet, G. Houvenaeghel, M. Gutowski, P. De Blay, J. L. Verhaeghe, E. Barranger, C. Lefebvre, C. Ngo, G. Ferron, C. Palpacuer, L. Campion
A randomized trial of interpersonal psychotherapy, problem solving therapy, and supportive therapy for major depressive disorder in women with breast cancer
Carlos Blanco, John C. Markowitz, David J. Hellerstein, Arthur M. Nezu, Melanie Wall, Mark Olfson, Ying Chen, Jon Levenson, Maika Onishi, Cindy Varona, Mayumi Okuda, Dawn L. Hershman
Machine learning for diagnostic ultrasound of triple-negative breast cancer
Tong Wu, Laith R. Sultan, Jiawei Tian, Theodore W. Cary, Chandra M. Sehgal
Discrepancy in risk assessment of hormone receptor positive early-stage breast cancer patients using breast cancer index and recurrence score
Piiha-Lotta Jerevall, Jane Brock, Juan Palazzo, Tad Wieczorek, Michael Misialek, Anthony J. Guidi, Yun Wu, Mark G. Erlander, Yi Zhang, Catherine A. Schnabel, Paul E. Goss, Nora Horick, Dennis C. Sgroi
Prevalence and oncologic outcomes of BRCA 1/2 mutations in unselected triple-negative breast cancer patients in Korea
Jai Min Ryu, Hee Jun Choi, Isaac Kim, Seok Jin Nam, Seok Won Kim, Jonghan Yu, Se Kyung Lee, Doo Ho Choi, Yeon Hee Park, Jong-Won Kim, Jeong-sun Seo, Jung-Hoon Park, Jeong Eon Lee, Sung-Won Kim
Oral etoposide in heavily pre-treated metastatic breast cancer: results from the ESME cohort and comparison with other chemotherapy regimens
Luc Cabel, Matthieu Carton, Bianca Cheaib, Jean-Yves Pierga, Florence Dalenc, Audrey Mailliez, Christelle Levy, William Jacot, Marc Debled, Marianne Leheurteur, Isabelle Desmoulins, Claudia Lefeuvre, Anthony Gonçalves, Lionel Uwer, Jean-Marc Ferrero, Jean-Christophe Eymard, Thierry Petit, Marie-Ange Mouret-Reynier, Geneviève Perrocheau, Irwin Piot, David Pérol, Gaëtane Simon, Florence Lerebours
Metronomic capecitabine combined with aromatase inhibitors for new chemoendocrine treatment of advanced breast cancer: a phase II clinical trial
Jian-wei Li, Wen-jia Zuo, Diana Ivanova, Xiao-qing Jia, Li Lei, Guang-yu Liu
The impact of gene expression profile testing on confidence in chemotherapy decisions and prognostic expectations
Laura Panattoni, Tracy A. Lieu, Jinani Jayasekera, Suzanne O’Neill, Jeanne S. Mandelblatt, Ruth Etzioni, Charles E. Phelps, Scott D. Ramsey
Which patients with sentinel node-positive breast cancer after breast conservation still receive completion axillary lymph node dissection in routine clinical practice?
André Hennigs, Melitta Köpke, Manuel Feißt, Fabian Riedel, Mahdi Rezai, Ulrike Nitz, Mareike Moderow, Michael Golatta, Christof Sohn, Andreas Schneeweiss, Jörg Heil
Improving the competency of medical students in clinical breast examination through a standardized simulation and multimedia-based curriculum
Fernando A. Angarita, Benjamin Price, Matthew Castelo, Mauricio Tawil, Juan Carlos Ayala, Lilian Torregrossa
The influence of reconstruction choice and inclusion of radiation therapy on functional shoulder biomechanics in women undergoing mastectomy for breast cancer
Joshua M. Leonardis, Brian J. Diefenbach, Daniel A. Lyons, Thomas A. Olinger, Aviram M. Giladi, Adeyiza O. Momoh, David B. Lipps
Multivariate machine learning models for prediction of pathologic response to neoadjuvant therapy in breast cancer using MRI features: a study using an independent validation set
Elizabeth Hope Cain, Ashirbani Saha, Michael R. Harowicz, Jeffrey R. Marks, P. Kelly Marcom, Maciej A. Mazurowski
Predictors of time to death after distant recurrence in breast cancer patients
Victoria Sopik, Ping Sun, Steven A. Narod
Body composition is associated with risk of toxicity-induced modifications of treatment in women with stage I–IIIB breast cancer receiving chemotherapy
Maaike M. G. A. van den Berg, Dieuwertje E. Kok, Liesbeth Posthuma, Lisette Kamps, Celine S. Kelfkens, Nicole Buist, Maud Geenen, Annebeth Haringhuizen, Joan B. Heijns, Rianne H. M. A. van Lieshout, Maartje Los, Dirkje W. Sommeijer, Johanna N. H. Timmer-Bonte, Anja Th. C. M. de Kruif, Hanneke W. M. van Laarhoven, Ellen Kampman, Renate M. Winkels
Better pathological tumor characteristics might occur in recurrent metastatic breast cancer patients after 10-year metastatic free interval
Kadri Altundag
Correction to: Efficacy and safety of fulvestrant in postmenopausal patients with hormone receptor-positive advanced breast cancer: a systematic literature review and meta-analysis
Jiayu Wang, Binghe Xu, Wenna Wang, Xiaoyu Zhai, Xuelian Chen